North America Clinical Trials Supplies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Clinical Trials Supplies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Clinical Trials Supplies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Clinical Trials Supplies Market Regional Analysis

6.2 North America Clinical Trials Supplies Market Revenue 2017-2027 (US$ Million)

6.3 North America Clinical Trials Supplies Market Forecast Analysis

7. North America Clinical Trials Supplies Market Analysis – by Product & Service

7.1 Manufacturing

7.1.1 Overview
7.1.2 Manufacturing: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Packaging & Labelling

7.2.1 Overview
7.2.2 Packaging & Labelling: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Logistics & Distribution

7.3.1 Overview
7.3.2 Logistics & Distribution: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Clinical Trials Supplies Market Analysis – by Stage

8.1 Phase I

8.1.1 Overview
8.1.2 Phase I: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Phase II

8.2.1 Overview
8.2.2 Phase II: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Phase III

8.3.1 Overview
8.3.2 Phase III: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Bioequivalence Studies

8.4.1 Overview
8.4.2 Bioequivalence Studies: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Clinical Trials Supplies Market Analysis – by Drug Type

9.1 Small-Molecule Drugs

9.1.1 Overview
9.1.2 Small-Molecule Drugs: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Biologic Drugs

9.2.1 Overview
9.2.2 Biologic Drugs: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Clinical Trials Supplies Market Analysis – by Application

10.1 Oncology

10.1.1 Overview
10.1.2 Oncology: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Cardiovascular Diseases

10.2.1 Overview
10.2.2 Cardiovascular Diseases: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.3 Neurological Disorders

10.3.1 Overview
10.3.2 Neurological Disorders: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.4 Respiratory Disorders

10.4.1 Overview
10.4.2 Respiratory Disorders: North America Clinical Trials Supplies Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. North America Clinical Trials Supplies Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Clinical Trials Supplies Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 North America Clinical Trials Supplies Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 US: North America Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.1.2 US: North America Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.1.3 US: North America Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.1.4 US: North America Clinical Trials Supplies Market Breakdown, by Application

11.2.1.2 Canada: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 Canada: North America Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.2.2 Canada: North America Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.2.3 Canada: North America Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.2.4 Canada: North America Clinical Trials Supplies Market Breakdown, by Application

11.2.1.3 Mexico : North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Mexico : North America Clinical Trials Supplies Market Breakdown, by Product & Service
11.2.1.3.2 Mexico : North America Clinical Trials Supplies Market Breakdown, by Stage
11.2.1.3.3 Mexico : North America Clinical Trials Supplies Market Breakdown, by Drug Type
11.2.1.3.4 Mexico : North America Clinical Trials Supplies Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 UDG Healthcare plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Catalent Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 pci Pharma Services

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Almac Group

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 PAREXEL INTERNATIONAL CORPORATION

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Biocair

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Owens & Minor Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Rubicon Research Pvt. Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Clinical Trials Supplies Market